Low-Dose Foscarnet Preemptive Therapy for Cytomegalovirus Viremia after Haploidentical Bone Marrow Transplantation

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 4, 2009, Pages 519-520

  Wang, Hengxiang ^a   Zhu, Ling ^a   Xue, Mei ^a   Liu, Jing ^a   Guo, Zikuan ^b  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYTOMEGALOVIRUS ANTIGEN PP65; FOSCARNET; GANCICLOVIR;

ANOREXIA; BONE MARROW DEPRESSION; COLITIS; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROLYTE BLOOD LEVEL; FEVER; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION PREVENTION; KIDNEY FAILURE; LETTER; LEUKOCYTE COUNT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NAUSEA; SIDE EFFECT; THROMBOCYTE COUNT; VIREMIA; VOMITING;

ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOSCARNET; HUMANS; MALE; PHOSPHOPROTEINS; TRANSPLANTATION, HOMOLOGOUS; VIRAL MATRIX PROTEINS; VIREMIA;

EID: 61749084994     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.12.510     Document Type: Letter

References (7)

1. Guinan E.C., Boussiotis V.A., Neuberg D., et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 340 (1999) 1704-1714
2. Wang H.X., Yan H.M., Duan L.N., et al. Haploidentical hematopoietic stem cell transplantation in children hematologic malignancies with G-CSF-mobilized marrow grafts without T cell depletion: a single-center report of 45 cases. Pediatr Hematol Oncol (2008) Accepted
3. Ji S.Q., Chen H.R., Wang H.X., et al. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor marrow priming in patients with chronic myelogenous leukemia. Biol Blood Marrow Transplant 8 (2002) 261-267
4. Ji S.Q., Chen H.R., Wang H.X., et al. G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia. Bone Marrow Transplant 30 (2002) 861-866
5. Ji S.Q., Chen H.R., Yan H.M., et al. Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies. Bone Marrow Transplant 36 (2005) 349-354
6. Yanada M., Yamamoto K., Emi N., et al. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 32 (2003) 801-807
7. Bacigalupo A., Bregante S., Tedone E., et al. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after hemopoietic stem cell transplantation (HSCT). Transplantation 62 (1996) 376-380